Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Caterina Mezzatesta"'
Autor:
Rocco Piazza, Vera Magistroni, Sara Redaelli, Mario Mauri, Luca Massimino, Alessandro Sessa, Marco Peronaci, Maciej Lalowski, Rabah Soliymani, Caterina Mezzatesta, Alessandra Pirola, Federica Banfi, Alicia Rubio, Delphine Rea, Fabio Stagno, Emilio Usala, Bruno Martino, Leonardo Campiotti, Michele Merli, Francesco Passamonti, Francesco Onida, Alessandro Morotti, Francesca Pavesi, Marco Bregni, Vania Broccoli, Marc Baumann, Carlo Gambacorti-Passerini
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-13 (2018)
SETBP1 variants occur as somatic mutations in several malignancies and as de novo germline mutations in developmental disorders. Here the authors provide evidence that SETBP1 binds to gDNA in AT-rich promoter regions to promote target gene upregulati
Externí odkaz:
https://doaj.org/article/ba93d3f63f634212b28426582bbfc01b
Autor:
Vera Magistroni, Mario Mauri, Deborah D’Aliberti, Caterina Mezzatesta, Ilaria Crespiatico, Miriam Nava, Diletta Fontana, Nitesh Sharma, Wendy Parker, Andreas Schreiber, David Yeung, Alessandra Pirola, Sara Readelli, Luca Massimino, Paul Wang, Praveen Khandelwal, Stefania Citterio, Michela Viltadi, Silvia Bombelli, Roberta Rigolio, Roberto Perego, Jacqueline Boultwood, Alessandro Morotti, Giuseppe Saglio, Dong-Wook Kim, Susan Branford, Carlo Gambacorti-Passerini, Rocco Piazza
Publikováno v:
Haematologica, Vol 104, Iss 9 (2019)
Despite the advent of tyrosine kinase inhibitors, a proportion of chronic myeloid leukemia patients in chronic phase fail to respond to imatinib or to second-generation inhibitors and progress to blast crisis. Until now, improvements in the understan
Externí odkaz:
https://doaj.org/article/dc1173e7f1cf43149a5eb961d6c7e2da
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 7 (2019)
Escape from chemotherapy-induced apoptosis is a hallmark of drug resistance in cancer. The recent identification of alternative programmed cell death pathways opens up for possibilities to circumvent the apoptotic blockade in drug resistant cancer an
Externí odkaz:
https://doaj.org/article/222c41bb2f5b4011b15e499fc8e70ec4
Autor:
Caterina Mezzatesta, Martin Schrappe, Marketa Zaliova, Arend von Stackelberg, Cornelia Eckert, Yi Chien Tsai, Beat Bornhauser, Anna Guinot, Gunnar Cario, Denis M. Schewe, Luciana Vinti, Blerim Marovca, Franco Locatelli, Martin Stanulla, Jean-Pierre Bourquin, Silvia Jenni, Júlia Aguadé-Gorgorió, Liridon Abduli
Publikováno v:
Blood Cancer Journal
Blood Cancer Journal, Vol 10, Iss 6, Pp 1-11 (2020)
Blood Cancer Journal, Vol 10, Iss 6, Pp 1-11 (2020)
Despite rapid progress in genomic profiling in acute lymphoblastic leukemia (ALL), identification of actionable targets and prediction of response to drugs remains challenging. To identify specific vulnerabilities in ALL, we performed a drug screen u
Autor:
Beat Bornhauser, Scott McComb, Caterina Mezzatesta, Silvia Jenni, Jean-Pierre Bourquin, Maria Pamela Dobay, Anna Guinot, Júlia Aguadé-Gorgorió, Martin Stanulla, Arend von Stackelberg, Liridon Abduli, Martin Schrappe, Gunnar Cario, Blerim Marovca, Cornelia Eckert
Publikováno v:
Blood Adv
Despite major advances in the treatment of patients with acute lymphoblastic leukemia in the last decades, refractory and/or relapsed disease remains a clinical challenge, and relapsed leukemia patients have an exceedingly dismal prognosis. Dysregula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a01b8c95089a4ba74af21b7cd81260d
Autor:
Alessandro Sessa, Luca Massimino, Marc Baumann, Fabio Stagno, Sara Redaelli, Francesco Onida, Francesco Passamonti, Emilio Usala, Delphine Rea, Leonardo Campiotti, Alicia Rubio, Alessandra Pirola, Vera Magistroni, Bruno Martino, Michele Merli, Vania Broccoli, Mario Mauri, Maciej Lalowski, Marco Peronaci, Marco Bregni, Rabah Soliymani, Alessandro Morotti, Rocco Piazza, Carlo Gambacorti-Passerini, Federica Banfi, Francesca Pavesi, Caterina Mezzatesta
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-13 (2018)
Nature Communications
Nature Communications
SETBP1 variants occur as somatic mutations in several hematological malignancies such as atypical chronic myeloid leukemia and as de novo germline mutations in the Schinzel–Giedion syndrome. Here we show that SETBP1 binds to gDNA in AT-rich promote
Autor:
Beat Bornhauser, Caterina Mezzatesta
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 7 (2019)
Frontiers in Cell and Developmental Biology
Frontiers in Cell and Developmental Biology
Escape from chemotherapy-induced apoptosis is a hallmark of drug resistance in cancer. The recent identification of alternative programmed cell death pathways opens up for possibilities to circumvent the apoptotic blockade in drug resistant cancer an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f801e752da8e888bc077cb6d443939f5
https://www.zora.uzh.ch/id/eprint/178767/
https://www.zora.uzh.ch/id/eprint/178767/
Autor:
Caterina Mezzatesta, David T Yeung, Miriam Nava, Alessandro Morotti, Carlo Gambacorti-Passerini, Jacqueline Boultwood, Deborah D'Aliberti, Roberta Rigolio, Luca Massimino, Wendy T Parker, Rocco Piazza, Diletta Fontana, Alessandra Pirola, Sara Readelli, Dong-Wook Kim, Nitesh Sharma, Andreas W. Schreiber, Mario Mauri, Ilaria Crespiatico, Susan Branford, Vera Magistroni, Giuseppe Saglio, R Perego, Praveen Khandelwal, Michela Viltadi, Paul Wang, Silvia Bombelli, Stefania Citterio
Publikováno v:
Haematologica
Despite the advent of tyrosine kinase inhibitors, a proportion of chronic myeloid leukemia patients in chronic phase fails to respond to Imatinib or to second generation inhibitors and progress to blast crisis. Limited improvements in the understandi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edd0137ab0ca425dfe8ea9490aff4a1e
http://hdl.handle.net/10281/230164
http://hdl.handle.net/10281/230164
Autor:
Bruno Martino, Anna Petroccione, Sarit Assouline, Pilar Giraldo, Chiara Elena, Patrizia Crivori, Agnese Lodolo D'Oria, Ivana Pierri, Ester Pungolino, Silvia Mori, Dong-Wook Kim, Sara Redaelli, Elisabetta Vagge, Philipp le Coutre, Caterina Mezzatesta, Anna D'Emilio, Rocco Piazza, Alessandra Iurlo, Giulia De Riso, Carlo Gambacorti-Passerini, Fabio Stagno, Michela Luciani, Antonella Gozzini, Elisabetta Abruzzese, Alessandra Pirola
Publikováno v:
American Journal of Hematology. 90:910-914
Imatinib is effective for the treatment of chronic myeloid leukemia (CML). However even undetectable BCR-ABL1 by Q-RT-PCR does not equate to eradication of the disease. Digital-PCR (dPCR), able to detect 1 BCR-ABL1 positive cell out of 10(7) , has be
Autor:
G Cario, Júlia Aguadé-Gorgorió, Scott McComb, Martin Schrappe, Martin Stanulla, C Eckert, Beat Bornhauser, Maria Pamela Dobay, Caterina Mezzatesta, A von Stackelberg, J-P Bourquin
Publikováno v:
Klinische Pädiatrie.